(+)-VINCRISTINE

CHOP

Fudan UniversitySmall moleculePhase 2Active

B

60/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 45/ 100
Competitive Position: 95/ 100

Competitive context

5 Active assets in the CHOP cohort.

Asset / Sponsor	Phase	Rating
Cyclophosphamide Fudan University	Phase 2	B
PREDNISONE TABLETS Fudan University	Phase 2	B
Inno-206 Fudan University	Phase 2	B
cc-5013 Second Affiliated Hospital, School of Medicine, Zhejiang University	Phase 2	CCC
Parsaclisib Fudan University	Phase 1/2	CCC

Same molecule, other indications

(+)-VINCRISTINE is also rated in:

anaplastic large cell lymphomaDormant

BBB

Indicative ·

78 / 100

mycosis fungoidesDormant

BBB

Indicative ·

78 / 100

adult acute lymphoblastic leukemiaDormant

BBB

Indicative ·

77 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.